R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability

NCUIR > college of Health Sciences and Technology > Department of Biomedical Sciences and Engineering > journal & Dissertation > Item 987654321/102907

Please use this identifier to cite or link to this item: https://ir.lib.ncu.edu.tw/handle/987654321/102907

Title:	R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability
Authors:	許藝瓊;Chen, Hsuan-Yu;Yu, Sung-Liang;Ho, Bing-Ching;Su, Kang-Yi;Hsu, Yi-Chiung;Chang, Chi-Sheng;Li, Yu-Cheng;Yang, Shi-Yi;Hsu, Pin-Yen;Ho, Hao;Chang, Ya-Hsuan;Chen, Chih-Yi;Yang, Hwai-I;Hsu, Chung-Ping;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Tseng, Jeng-Sen;Hsia, Jiun-Yi;Chuang, Cheng-Yen;Yuan, Shinsheng;Lee, Mei-Hsuan;Liu, Chia-Hsin;Wu, Guan-I;Hsiung, Chao A.;Chen, Yuh-Min;Wang, Chih-Liang;Huang, Ming-Shyan;Yu, Chong-Jen;Chen, Kuan-Yu;Tsai, Ying-Huang;Su, Wu-Chou;Chen, Huei-Wen;Chen, Jeremy J.W.;Chen, Chien-Jen;Chang, Gee-Chen;Yang, Pan-Chyr;Li, Ker-Chau
Contributors:	生醫理工學院生醫科學與工程學系
Date:	2015-07-10
Issue Date:	2026-04-23 11:19:53 (UTC+8)
Publisher:	American Society of Clinical Oncology;American Society of Clinical Oncology (ASCO)
Abstract:	摘要： Purpose Adenocarcinoma is the most dominant type of lung cancer in never-smoker patients. The risk alleles from genome-wide association studies have small odds ratios and unclear biologic roles. Here we have taken an approach featuring suitable medical actionability to identify alleles with low population frequency but high disease-causing potential. Patients and Methods Whole-genome sequencing was performed for a family with an unusually high density of lung adenocarcinoma with available DNA from the affected mother, four affected daughters, and one nonaffected son. Candidate risk alleles were confirmed by matrix-assisted laser desorption ionization time of flight mass spectroscopy. Validation was conducted in an external cohort of 1,135 participants without cancer and 1,312 patients with lung adenocarcinoma. Family follow-ups were performed by genotyping the relatives of the original proband and the relatives of the identified risk-allele carriers. Low-dose computed tomography scans of the chest were evaluated for lung abnormalities. Results YAP1 R331W missense mutation from the original family was identified and validated in the external controls and the cohort with lung adenocarcinoma. The YAP1 mutant-allele carrier frequency was 1.1% in patients with lung adenocarcinoma compared with 0.18% in controls (P = .0095), yielding an odds ratio (adjusted for age, sex, and smoking status) of 5.9. Among the relatives, YAP1-mutant carriers have overwhelmingly higher frequencies of developing lung adenocarcinoma or ground-glass opacity lung lesions than those who do not carry the mutation (10:0 v 1:7; P < .001). YAP1 mutation was shown to increase the colony formation ability and invasion potential of lung cancer cells. Conclusion These results implicated YAP1 R331W as an allele predisposed for lung adenocarcinoma with high familial penetrance. Low-dose computed tomography scans may be recommended to this subpopulation, which is at high risk for lung cancer, for personalized prevention and health management. 出版者： American Society of Clinical Oncology (ASCO) 出版日期： 2015-07-10 出處： Journal of Clinical Oncology, 2015-07, Vol.33 (20), p.2303-2310 識別號： ISSN: 0732-183X 識別號： DOI: 10.1200/jco.2014.59.3590
Appears in Collections:	[Department of Biomedical Sciences and Engineering ] journal & Dissertation

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	18	View/Open

社群 sharing

Loading...